295 related articles for article (PubMed ID: 20136841)
1. GPR55 ligands promote receptor coupling to multiple signalling pathways.
Henstridge CM; Balenga NA; Schröder R; Kargl JK; Platzer W; Martini L; Arthur S; Penman J; Whistler JL; Kostenis E; Waldhoer M; Irving AJ
Br J Pharmacol; 2010 Jun; 160(3):604-14. PubMed ID: 20136841
[TBL] [Abstract][Full Text] [Related]
2. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
[TBL] [Abstract][Full Text] [Related]
3. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
[TBL] [Abstract][Full Text] [Related]
4. The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling.
Ruz-Maldonado I; Liu B; Atanes P; Pingitore A; Huang GC; Choudhary P; Persaud SJ
Cell Mol Life Sci; 2020 Nov; 77(22):4709-4723. PubMed ID: 31925452
[TBL] [Abstract][Full Text] [Related]
5. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
Nevalainen T; Irving AJ
Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
[TBL] [Abstract][Full Text] [Related]
6. The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55.
Kargl J; Balenga NA; Platzer W; Martini L; Whistler JL; Waldhoer M
Br J Pharmacol; 2012 Apr; 165(8):2611-9. PubMed ID: 21718301
[TBL] [Abstract][Full Text] [Related]
7. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
[TBL] [Abstract][Full Text] [Related]
8. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors.
Anavi-Goffer S; Irving AJ; Ross RA
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417
[TBL] [Abstract][Full Text] [Related]
9. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
[TBL] [Abstract][Full Text] [Related]
10. Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.
Balenga NA; Martínez-Pinilla E; Kargl J; Schröder R; Peinhaupt M; Platzer W; Bálint Z; Zamarbide M; Dopeso-Reyes IG; Ricobaraza A; Pérez-Ortiz JM; Kostenis E; Waldhoer M; Heinemann A; Franco R
Br J Pharmacol; 2014 Dec; 171(23):5387-406. PubMed ID: 25048571
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
[TBL] [Abstract][Full Text] [Related]
12. Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning.
Mosca MG; Mangini M; Cioffi S; Barba P; Mariggiò S
Cell Commun Signal; 2021 Apr; 19(1):48. PubMed ID: 33902596
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
Sharir H; Abood ME
Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
[TBL] [Abstract][Full Text] [Related]
14. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
[TBL] [Abstract][Full Text] [Related]
15. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.
Obara Y; Ueno S; Yanagihata Y; Nakahata N
PLoS One; 2011; 6(8):e24284. PubMed ID: 21904624
[TBL] [Abstract][Full Text] [Related]
17. The orphan receptor GPR55 is a novel cannabinoid receptor.
Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
[TBL] [Abstract][Full Text] [Related]
18. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.
Piñeiro R; Maffucci T; Falasca M
Oncogene; 2011 Jan; 30(2):142-52. PubMed ID: 20838378
[TBL] [Abstract][Full Text] [Related]
19. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.
Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ
Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953
[TBL] [Abstract][Full Text] [Related]
20. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.
Bondarenko A; Waldeck-Weiermair M; Naghdi S; Poteser M; Malli R; Graier WF
Br J Pharmacol; 2010 Sep; 161(2):308-20. PubMed ID: 20735417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]